Capsaicin 8% Patch
Capsaicin 8% Patch is a pharmaceutical drug with 7 clinical trials. Currently 4 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
4
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
Marsili Syndrome as a Gateway to Novel Analgesic Targets
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.
Topographical Distribution of Itch and Pain Receptors
Clinical Trials (7)
Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
Marsili Syndrome as a Gateway to Novel Analgesic Targets
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.
Topographical Distribution of Itch and Pain Receptors
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7